ACADIA Pharmaceuticals
ACAD
#3220
Rank
NZ$7.86 B
Marketcap
NZ$46.48
Share price
-2.22%
Change (1 day)
44.67%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.71 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.71 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ACADIA Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.80 B60.83%
2023-12-31NZ$0.50 B69.93%
2022-12-31NZ$0.29 B26.62%
2021-12-31NZ$0.23 B8.09%
2020-12-31NZ$0.21 B72.81%
2019-12-31NZ$0.12 B36.95%
2018-12-31NZ$91.12 M31.48%
2017-12-31NZ$69.3 M12.32%
2016-12-31NZ$61.7 M90.8%
2015-12-31NZ$32.33 M58.68%
2014-12-31NZ$20.38 M139.71%
2013-12-31NZ$8.5 M-70.37%
2012-12-31NZ$28.69 M155.89%
2011-12-31NZ$11.21 M-0.63%
2010-12-31NZ$11.28 M-78.18%
2009-12-31NZ$51.72 M156.86%
2008-12-31NZ$20.13 M-25.31%
2007-12-31NZ$26.95 M-15.16%
2006-12-31NZ$31.77 M-6.13%
2005-12-31NZ$33.84 M149.38%
2004-12-31NZ$13.57 M-89.54%
2003-12-31NZ$0.12 B21.04%
2002-12-31NZ$0.10 B986.72%
2001-12-31NZ$9.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
NZ$0.23 B-67.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.33 B 27,865.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$157.80 B 21,927.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.70 B 27,358.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.63 B 18,833.30%๐Ÿ‡บ๐Ÿ‡ธ USA